izpis_h1_title_alt

Genetic variability of the vitamin D receptor affects susceptibility to Parkinson's disease and dopaminergic treatment adverse events
ID Redenšek Trampuž, Sara (Author), ID Kristanc, Tilen (Author), ID Blagus, Tanja (Author), ID Trošt, Maja (Author), ID Dolžan, Vita (Author)

.pdfPDF - Presentation file, Download (279,78 KB)
MD5: C54388CCDE61C42CFE19099F22E0E5FC
URLURL - Source URL, Visit https://www.frontiersin.org/articles/10.3389/fnagi.2022.853277/full This link opens in a new window

Abstract
Vitamin D is a lipid-soluble molecule and an important transcriptional regulator in many tissues and organs, including the brain. Its role has been demonstrated also in Parkinson’s disease (PD) pathogenesis. Vitamin D receptor (VDR) is responsible for the initiation of vitamin D signaling cascade. The aim of this study was to assess the associations of VDR genetic variability with PD risk and different PD-related phenotypes. We genotyped 231 well characterized PD patients and 161 healthy blood donors for six VDR single nucleotide polymorphisms, namely rs739837, rs4516035, rs11568820, rs731236, rs2228570, and rs1544410. We observed that VDR rs2228570 is associated with PD risk (p < 0.001). Additionally, we observed associations of specific VDR genotypes with adverse events of dopaminergic treatment. VDR rs1544410 (GG vs. GA + AA: p = 0.005; GG vs. GA: p = 0.009) was associated with the occurrence of visual hallucinations and VDR rs739837 (TT vs. GG: p = 0.036), rs731236 (TT vs. TC + CC: p = 0.011; TT vs. TC: p = 0.028; TT vs. CC: p = 0.035), and rs1544410 (GG vs. GA: p = 0.014) with the occurrence of orthostatic hypotension. We believe that the reported study may support personalized approach to PD treatment, especially in terms of monitoring vitamin D level and vitamin D supplementation in patients with high risk VDR genotypes.

Language:English
Keywords:vitamin D receptor, Parkinson’s disease, biomarker, risk, susceptibility, adverse events, vitamin D, polymorphism
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:9 str.
Numbering:Vol. 14, art. 853277
PID:20.500.12556/RUL-145377 This link opens in a new window
UDC:616.8
ISSN on article:1663-4365
DOI:10.3389/fnagi.2022.853277 This link opens in a new window
COBISS.SI-ID:101668611 This link opens in a new window
Publication date in RUL:19.04.2023
Views:304
Downloads:55
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Frontiers in aging neuroscience
Shortened title:Front. aging neurosci.
Publisher:Frontiers Media
ISSN:1663-4365
COBISS.SI-ID:20576008 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:nevrologija, Parkinsonova bolezen, receptor vitamina D, nevroznanost

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0170
Name:Molekulski mehanizmi uravnavanja celičnih procesov v povezavi z nekaterimi boleznimi pri človeku

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back